Author: Revelation Biosciences, Inc.

Posted Date:

April 6, 2026

Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

Revelation Biosciences, Inc.

April 6, 2026
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study

Revelation Biosciences, Inc.

March 30, 2026
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

Revelation Biosciences, Inc.

March 19, 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

Revelation Biosciences, Inc.

February 27, 2026
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026

Revelation Biosciences, Inc.

January 28, 2026
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds

Revelation Biosciences, Inc.

January 28, 2026